Stephen N. Oesterle

CIK 1174532 · SrVP Medicine & Technology · last filed 2025-05-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$4.93M

Companies

5

Total Filings

35

Lifetime Open-Market Net

-$694.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
BAX	Director	35,847	$20.86	$747.8K	$0	10	2025-05-08
Paragon 28, Inc. (FNA) Delisted	Director	0	$13.09	$0	$0	5	2025-04-21
Sigilon Therapeutics, Inc. (SGTX) Delisted	Director	—	$22.47	—	$0	5	2023-08-11
HeartWare International, Inc. (HTWR) Delisted	Director	0	—	—	$32.2K	4	2016-08-24
MDT	SrVP Medicine & Technology	52,209	$80.20	$4.19M	-$726.5K	9	2009-08-05

Recent Filings · Page 4 of 4

35 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2008-04-29	MDT	Grant (A)	+19,865	$0	EDGAR
2007-10-31	MDT	Grant (A)	+5,234	$0	EDGAR
2007-08-27	MDT	Gift (G)	—	$0	EDGAR
2007-06-08	MDT	Mixed	+1,708	-$66.9K	EDGAR
2007-04-19	MDT	Mixed	−21,089	-$1.10M	EDGAR

Showing 31–35 of 35

Prev Page 4 of 4

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.